Therapeutic Sciences Graduate Program

High-aspect-ratio nanoparticles (HARPs) exhibit an extraordinary ability to stimulate activation, proliferation, and death in various cell types. We aim to use this platform to fabricate functionalized poly(caprolactone) (PCL) nanowires to target and influence immune cell activity. In the Desai Lab, my research focuses on evaluating the versatility of this platform in conjunction with novel antibody therapies in an effort to impact the treatment of immune-related morbidities.